Search for dissertations about: "highly malignant lymphoma"

Showing result 1 - 5 of 19 swedish dissertations containing the words highly malignant lymphoma.

  1. 1. Protein kinases and phosphatases in B-cell lymphoma

    University dissertation from Inst för Laboratoriemedicin, Avd för tumörbiologi, Malmö Universitetssjukhus, Lunds Universitet

    Author : Marie Fridberg; [2009]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; HePTP; PTEN; PKC-beta 2; B-cell; lymphoma; kinases; ZAP70; phosphatase; SHP2;

    Abstract : Around 2000 persons are diagnosed with lymphoma in Sweden each year. There are many subgroups described for this form of cancer and the great majority is derived from B-cells. The most common subgroup is Diffuse large B-cell lymphoma (DLBCL), a highly aggressive disease where only half of the patients are cured. READ MORE

  2. 2. Daily life problems from a nursing perspective in patients with acute leukaemia or highly malignant lymphoma

    University dissertation from Lund : Centre of caring sciences, The medical faculty, Lund Univ

    Author : Lena Persson; Högskolan Kristianstad.; [1998]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; INTERDISCIPLINARY RESEARCH AREAS Caring sciences Nursing; TVÄRVETENSKAPLIGA FORSKNINGSOMRÅDEN Vårdvetenskap Omvårdnad; Nursing Care; acute leukaemia; quality of life; sense of coherence; family; spouses; nursing care; highly malignant lymphoma; Physical medicine; kinesitherapy; revalidation; rehabilitation; Rehabilitering medicinsk och social ;

    Abstract : Livskvalitet och problem i dagligt liv under och efter akut leukemi eller högmalignt lymfom - ett omvårdnadsperspektiv.Syftet med avhandlingen var att undersöka hur personer med akut leukemi eller hög- malignt lymfom upplevde och hanterade de problem som uppstod i det dagliga livet i samband med sjukdom och behandling och efter det att behandlingen avslutats. READ MORE

  3. 3. Prognostic Markers in Diffuse Large B-cell Lymphoma How Bad can it be

    University dissertation from Uppsala : Acta Universitatis Upsaliensis

    Author : Gustaf Hedström; Uppsala universitet.; [2014]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; DLBCL; Survival; Mast cell; Microenvironment; MicroRNA; MDM2; Polymorphism; Age; Epidemiology; Oncology; Onkologi;

    Abstract : Diffuse large B-cell lymphoma (DLBCL), which is the most common type of lymphoma, is characterised by its aggressiveness and poor outcome without adequate treatment and also for its biological and clinical heterogeneity. It is therefore highly desirable to gain a more profound understanding of the underlying biology of the disease, as well as predictive factors for the guidance of treatment. READ MORE

  4. 4. Apoptosis signaling in leukemia and lymphoma: understanding mechanisms of chemoresistance

    University dissertation from Stockholm : Karolinska Institutet, Institute of Environmental Medicine

    Author : Astrid Ottosson Wadlund; Karolinska Institutet.; Karolinska Institutet.; [2011]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES;

    Abstract : Apoptosis (programmed cell death) is a basic physiological process, essential in the balance between life and death of cells of normal tissues in the body. Apoptosis can be considered as cellular “suicide” initiated by the cell itself when infected by a virus or transformed into a cancer cell. READ MORE

  5. 5. Tumor-targeted superantigens for experimental immunotherapy of human leukemia/lymphoma

    University dissertation from Uppsala : Acta Universitatis Upsaliensis

    Author : Cecilia Weigelt; Uppsala universitet.; [1998]
    Keywords : MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Oncology; SAg; SEA; SEAm; HLA class II; TCR; CFL; SDCC; cytotoxicity; TNF a; IFN g; mAb; PA-SEAm; anti-CD19-Fab-SEAm; B-CLL; B-NHL; AML; CML; immunotherapy; Onkologi; MEDICINE Surgery Oncology; MEDICIN Kirurgi Onkologi; Clinical Immunology; klinisk immunologi;

    Abstract : Bacterial superantigens (SAgs) have the property of stimulating high proportions of T cells expressing certain TCR Vβ sequences. The SAg first binds with high affinity to HLA class II molecules on the target cell and then stimulates the T cell to produce cytokines and to become cytotoxic. READ MORE